A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes

NCT02750410 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Dulaglutide
DRUG: Placebo

Sponsor

Eli Lilly and Company